Read + Share
Amedeo Smart
Independent Medical Education
Haakensen VD, Ojlert AK, Thunold S, Farooqi S, et al. UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial. Eur J Cancer 2024;202:113973.PMID: 38447379
Email
LinkedIn
Facebook
Twitter
Privacy Policy